MeRes100 BRS shows better long-term results in CAD patients
Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Jul 19
Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis…
12 Jul 19
Results showing arthroscopic surgery for knee problems is more accurate than MRI were presented at the Orthopedic Society…
Philips is pioneering research into the next generation of CT imaging: Spectral Photon Counting CT (SPCCT), as part…
Keystone Heart announced that it has signed a distribution agreement with Ireland-based Vasorum for sales and marketing of…
Royal Philips, a global leader in health technology, announced successful implementation of its Philips IntelliSite Pathology Solution at…
BioTime has announced the dosing of the first patient in its ongoing Phase I/IIa clinical study for the…
Agilent Technologies has signed an agreement to acquire US-based BioTek Instruments for around $1.165bn (£929m).
Generex Biotechnology has completed the acquisition of Pantheon Medical Foot & Ankle, a manufacturer of speciality orthopaedic surgery…
12 Jul 19
OrSense, a leading developer of systems for non-invasive measurements of haemoglobin, announces the selection of its NBM-200 non-invasive…
12 Jul 19
Veravas, an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic…